McGrath Emmett

Average Profitability
77.71%
Insider Buys Quantity
6
Insider Buys Sum
$99,926.74
Insider Sells Quantity
9
Insider Sells Sum
$4.59M

Insider Activity of McGrath Emmett

The largest purchase of all time was on 2013-03-31 and amounted to 1370 shares of ASGN Incorporated for $23,220.

The largest sale of all time was on 2013-12-06 and amounted to 40000 shares of ASGN Incorporated for $1.32M.

Biography of McGrath Emmett

No biography is available at this moment.

2013-12-06SaleASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
40,000
0.075%
$33.00$1.32M+0.79%
2013-09-10SaleASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
55,000
0.0589%
$18.97$1.04M+2.92%
2013-05-14SaleASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
25,000
0.0315%
$17.94$448,571+23.34%
2013-03-31PurchaseASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
1,370
0.0017%
$16.95$23,220
2012-12-11SaleASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
14,618
0.0275%
$19.50$285,063+35.07%
2012-03-31PurchaseASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
2,278
0.002%
$5.74$13,070
2012-02-24SaleASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
18,000
0.0483%
$13.99$251,843+25.14%
2011-11-02SaleASGN Incorporated
ASGN
Pres, Life Sciences &Allied HC
29,452
0.0789%
$10.29$303,069+54.51%
2011-09-30PurchaseASGN Incorporated
ASGN
President, Lab Support
2,146
0.0049%
$6.01$12,896+114.85%
2011-03-31PurchaseASGN Incorporated
ASGN
President, Lab Support
2,804
0.0037%
$4.60$12,894+8.88%
2011-02-23SaleASGN Incorporated
ASGN
President, Lab Support
40,000
0.1096%
$10.02$400,876+0.3%
2009-03-03PurchaseASGN Incorporated
ASGN
President, Lab Support
10,240
0.0313%
$1.95$19,966+153.37%
2007-08-22SaleASGN Incorporated
ASGN
President, Lab Support
40,000
0.1132%
$11.18$447,052-32.56%
2006-05-08SaleASGN Incorporated
ASGN
President, Lab Support U.S.
17,000
0.0265%
$5.34$90,846-13.22%
2005-09-13PurchaseASGN Incorporated
ASGN
President, Lab Support U.S.
2,400
0.0089%
$7.45$17,880+33.76%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.